These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15485477)

  • 1. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.
    Wallenfeldt K; Fagerberg B; Wikstrand J; Hulthe J
    J Intern Med; 2004 Nov; 256(5):413-20. PubMed ID: 15485477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced increases in oxidized low-density lipoprotein are associated with adverse outcomes in chronic heart failure.
    Jorde UP; Colombo PC; Ahuja K; Hudaihed A; Onat D; Diaz T; Hirsh DS; Fisher EA; Tseng CH; Vittorio TJ
    J Card Fail; 2007 Nov; 13(9):759-64. PubMed ID: 17996825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
    Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin.
    Matsumoto T; Takashima H; Ohira N; Tarutani Y; Yasuda Y; Yamane T; Matsuo S; Horie M
    J Am Coll Cardiol; 2004 Jul; 44(2):451-7. PubMed ID: 15261947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
    Kim HJ; Ahn CW; Kang ES; Myoung SM; Cha BS; Won YJ; Lim SK; Kim KR; Huh KB; Lee HC
    J Diabetes Complications; 2007; 21(1):7-12. PubMed ID: 17189868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients.
    Sevinc Ok E; Kircelli F; Asci G; Altunel E; Ertilav M; Sipahi S; Bozkurt D; Duman S; Ozkahya M; Toz H; Ok E
    Hemodial Int; 2012 Jul; 16(3):334-41. PubMed ID: 22497657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
    Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study.
    Langlois MR; Rietzschel ER; De Buyzere ML; De Bacquer D; Bekaert S; Blaton V; De Backer GG; Gillebert TC;
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1563-8. PubMed ID: 18511698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
    Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
    Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein lipofuscin-like fluorophores in men with coronary artery disease treated with statins.
    Sutherland WH; Williams MJ; de Jong SA
    Arch Med Res; 2007 Oct; 38(7):757-63. PubMed ID: 17845895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.